Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis. [electronic resource]
Producer: 20160505Description: 650-60 p. digitalISSN:- 2376-1032
- Adult
- Databases, Factual
- Drug Administration Schedule
- Drug-Related Side Effects and Adverse Reactions -- diagnosis
- Female
- Humans
- Immunologic Factors -- administration & dosage
- Injections, Subcutaneous
- Insurance Claim Review
- Insurance, Pharmaceutical Services
- Interferon-alpha -- administration & dosage
- Male
- Medicare
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Patient Safety
- Product Surveillance, Postmarketing
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- United States -- epidemiology
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.